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For many purposes the most useful transplantable
tumour models for human cancer are spontaneous
tumours, non-immunogenic in their original host
strain, whose cells are also capable of growth in
vitro. The necessity for spontaneous origin and
demonstrable non-immunogenicity results from the
misleading conclusions which may be drawn from
experiments using "induced" immunogenic tumours
which may be relatively poor models of cancer in
man (Hewitt et al., 1976; Hewitt, 1978).
It is evident that special value attaches to
transplantable experimental tumours which are also
capable of culture in vitro, so allowing a range of
clinically relevant studies to be carried out. Though
many of these in vitro-in vivo tumour systems have
been described (Rockwell, 1980), surprisingly few
are of spontaneous origin and known to be non-
immunogenic. Of experimental tumours in common
use, only the RIF-l tumour (Twentyman et al.,
1980) qualifies in each of these respects. Evidently
there exists a need for further spontaneous non-
immunogenic tumours capable of growth in vitro,
to widen the spectrum of putative models of human
cancer.
In this paper, we describe a new tumour system
which fulfils the criteria outlined above. This
tumour originated in 1968 when it arose
spontaneously in a 13 month old retired breeder
female mouse of the C57B-/Icrfa+ ("Black and
Tan") strain. The tumour comprised a very firm
mass involving the thigh and apparently composed
of cartilage and bony protuberances. Histological
studies identified the tumour as an osteosarcoma,
with newly formed bone, osteoid and cartilage and
with two main cell types, one resembling a normal
osteoblast and one a fibroblast (see Franks et al.,
1973; the tumour described here was designated as
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AE 165 in that report). Since 1968, the tumour
usually remained in liquid nitrogen, with infrequent
transplantation, and then only in syngeneic mice.
The present studies were initiated in 1982, and
made use of tumours which were between five and
nine transplantation generations from the original.
Further histology studies were carried out and
revealed histological evolution to have taken place.
The transplanted tumour was found to have the
morphology of a spindle cell sarcoma which was
infiltrating the dermis, subcutaneous fat and
underlying voluntary muscle. Patches of central
coagulative necrosis were present but convincing
evidence of tumour-derived bone or osteoid was
not found. One striking feature of the tumour was
its tendency to colonise striated muscle, producing
a pseudo-alveolar pattern as a result. Another was
an infiltration of arterial walls with extension of
tumour between the internal elastic lamina and
endothelium resulting in narrowing of the vascular
lumen. In some sections, the markedly basophilic
collagen network in necrotic areas and amorphous
material in empty muscle tubes were undergoing
finely granular and widespread calcification. The
histological features of the tumour are exemplified
by the sections shown in Figure 1. The tumour is
currently designated "spontaneous transplantable
sarcoma" or STS.
In earlier studies using this tumour (Franks et al.,
1973), serial transplantation was carried out by
implantation of tumour fragments. In the present
series of experiments, however, the tumour was
disaggregated enzymatically following excisions (3h
incubation at 37°C with collagenase, 2mgml-')
and transplantation achieved by inoculation of a
small quantity of cell suspension into the
gastronemius muscle of either hind limb. Tumours
grew from such inoculation with a somewhat
variable latent period which was, however, rarely
longer than 2 months at the smallest inoculation
size. In the macroscopic growth phase, the tumour
was found to be relatively slowly growing for a
murine neoplasm with a doubling time of -5 days
for the smallest measurable tumour (- 5mm diam.)
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lengthening to - 11-12 days for tumours with a
diameter of 8-10mm (see Figure 2).
In order to assess immunogenicity, a simple TD-
50 test was carried out. Though this is not the most
ngorous procedure possible, the majority of
experimental tumours in common use fail this test
(Hewitt, 1978) which constitutes a minimal criterion
for absence of immunogenicity. Mice were allocated
randomly to one of two groups (-30 mice in each)
which received graded quantities of viable tumour
cells, or two inocula (3 weeks apart) of 106
radiation sterilized cells followed (one week later)
by graded quantities of viable cells. Mice were
examined at weekly intervals for up to 4 months
thereafter and the proportion of tumour "takes" in
each group recorded as a function of the size of the
inoculation of viable cells. Figure 3 shows the
dependence proportion of "takes" on number of
viable cells inoculated. The data were fitted to a
Poisson model by the method of Porter & Berry
(1963) and found to conform well to single-cell
transplantation statistics. Estimates were made of
the TD50 value (number of cells to give 50%
"takes") in each group. The TD50 for the mice
which received viable cells only was found to be
1.5 x 102 cells and that for the mice which
additionally received prior inocula of radiation-
sterilized cells was found to be 1.8 x 102. These
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Figure 1 (a) Section of the tumour consisting of
spindle-shaped cells with ellipsoid nuclei and scanty,
amorphous or fibrillar, intercellular material. H & E;
bar represents 20pm. (b) Tumour cells separating and
partially or even totally replacing individual striated
muscle cells to assume a pseudo-alveolar pattern. H &
E; bar represents 50pm. (c) An artery with tumour
cells in the adventitia and inside the internal elastic
membrane, reducing the vascular lumen to a capillary
size. Weigert's resorcin fuschsin/H & E; bar represents
5Opm.
Figure 2 A putative growth curve for STS. The mean
tumour diameter was measured in mm, the volume
estimated and plotted log-linearly against time in days.
Two values of diameter (5mm and 10mm) are also
indicated on the ordinate. The growth curve is
Gompertzian in form, but may be usefully
approximated by two exponential curves with doubling
times of -5 and -11.5 days at smaller and larger
sizes, respectively. The individual points are median
values for groups of 4-8 mice and the indicated errors
are approximate 95% confidence limits for the median
calculated by the method of Nairn (cited by
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coated flasks in a concentration of -106 cells per
flask. The cells were then incubated as for
monolayer culture. Within a few days, loose
aggregates of cells had formed and some of these
aggregates were individually transferred, using a
Pasteur pipette, to agar-base-coated wells of 24-well
test plates (Linbro) each containing 1ml complete
medium. Over a period of 1-2 weeks, irregular
clumps of (typically) 150-300pm diam. were seen
to grow to form more uniform spherical masses in
excess of 900jmdiam. These studies confirm the
capacity of STS cells to form spheroids in vitro and
the capacity of the spheroids for independent
growth.
103 1o4 In summary we have described a new murine in
vitro-in vivo tumour system which has the following
properties:
Figure 3 Progressive increase in proportion of
tumour "takes" with size of cell inoculum per mouse
for intact mice (0) and for mice previously inoculated
with heavily irradiated tumour cells ( x).
TD50 values are not significantly different. Hence,
the tumour is "non-immunogenic" as judged by
this criterion.
Experiments were also carried out to assess the
ability of disaggregated tumour cells to grow in
vitro. These cells were seeded into 80cm2
"Nunclon" flasks (Gibco) containing 30ml full
medium and incubated at 37°C in a humidified
atmosphere at 5% CO2 in air. The medium was
composed of Eagle's minimum essential medium
with sodium bicarbonate (Gibco) supplemented
with 15% foetal calf serum (Gibco) and antibiotics
(penicillin 500 uml-1, streptomycin 0.5mgml-1).
The cells were sub-cultured routinely, once a week.
STS cells form colonies when plated on to tissue
culture petri-dishes with a plating efficiency of 35%
If heavily irradiated "feeder" STS cells have been
plated on to the dishes previously then the
maximum plating efficiency rose to 47% when 103
"feeder" cells per dish were present. The in vitro
population doubling time of STS cells, as estimated
from growth curves, was found to be -27 hours. It
was observed also that cells growing in culture, if
re-inoculated into mice, gave rise to solid tumours
which had the same morphology as tumours
transplanted in vivo throughout.
In order to test the capacity of the tumour cells
for spheroid formation, spheroid production was
initiated by the method of Yuhas et al. (1978).
Briefly, culture flasks of 75cm2 surface area were
prepared by base-coating with 0.75-1.00% Noble
agar (Difco), 10ml in total, in complete medium as
for monolayer culture. Cells growing in monolayer
culture were removed from the surface of the petri
dish by trypsinization and transferred to the base-
(1) Spontaneous origin as an osteosarcoma
followed by histological evolution to a
fibrosarcoma-like morphology.
(2) An unusual pattern of tumour cell infiltration
of adjacent normal tissues with a predilection
for arterial walls and striated muscle tubes.
(3) Non-immunogenicity in C57 B/T mice as
judged by TD50 test, and conformity with
Poisson transplantation statistics.
(4) Slow growth (for a mouse tumour) within the
visible size range.
(5) Growth in monolayer culture with a plating
efficiency of 40% and ease of transfer
between the in vitro and in vivo states in either
direction.
(6) Spheroid formation by the agar overlay method
and independent growth of the spheroids so
formed.
Disadvantages of the tumour system, however,
include an irregular and longitudinal pattern of
tumour growth making accurate assessment of
tumour size relatively difficult. It should be noted
that. C57 B/T mice are not good breeders.
Nevertheless, the paucity of in vitro-in vivo systems
possessing the desirable features described make it
probable that STS can be considered a useful
addition to the group of experimental tumours with
which in vitro studies can be performed, and which
conform to minimal criteria for suitability as
models of human cancer.
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